Targeted Radionuclide Therapy (TRT) is an expanding field of cancer treatment in which radiopharmaceuticals—comprising a radionuclide linked to a tumour-targeting biological vector—are administered to deliver cytotoxic radiation doses selectively to malignant tissues. The growing development of theragnostic agents, enabling both imaging and therapy, has strengthened the rationale for a patient-specific treatment approach. In clinical trials, […]
Future Health Lab
Alfred-Adler-Straße 1, Vienna, Austria
"Bringing Therapy Radioisotopes into Clinical Radiopharmacy" is an advanced course designed to bridge the gap between isotope production, radiopharmaceutical preparation and clinical application. This course focuses on the practical and regulatory hurdles of integrating therapeutic radionuclides into hospital settings. Diving into production and purification methods of emerging therapeutic isotopes, supply chain and matched pairs for theranostics, […]